Suchergebnisse - "Biard, Lucie"

PubPharm (96)

21

DICE : A Bayesian model for early dose finding in phase I trials with multiple treatment courses

enthalten in: Biometrical journal. Biometrische Zeitschrift | 2022

von Ursino, M. | Biard, L. | Chevret, S.

22

Challenges of using external data in clinical trials- an illustration in patients with COVID-19

enthalten in: BMC medical research methodology | 2022

von Chevret, S. | Timsit, J. | Biard, L.

23

Challenges of using external data in clinical trials- an illustration in patients with COVID-19

enthalten in: BMC medical research methodology | 2022

von Chevret, S. | Timsit, J. | Biard, L.

24

Challenges of using external data in clinical trials- an illustration in patients with COVID-19

enthalten in: BMC medical research methodology | 2022

von Chevret, S. | Timsit, J. | Biard, L.

25

Managing immune checkpoint inhibition in transplant recipients

enthalten in: The Lancet. Oncology | 2022

von Lebbé, C. | Biard, L. | Delyon, J. | +1

CommentOn: Lancet Oncol. 2022 Aug;23(8):1078-1086. - PMID 35809595

26

Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome

enthalten in: The British journal of dermatology | 2022

von Roelens, M. | de Masson, A. | Andrillon, A. | +8

27

Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis : A Multicenter Study of 330 Patients

enthalten in: American journal of ophthalmology | 2022

von Maalouf, G. | Andrillon, A. | Leclercq, M. | +18

28

Cerebrovascular Ischemic Events in Patients With Takayasu Arteritis

enthalten in: Stroke | 2022

von Mirouse, A. | Deltour, S. | Leclercq, D. | +16

29

Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema : A Multicenter Study from the French Uveitis Network

enthalten in: Ophthalmology | 2022

von Leclercq, M. | Andrillon, A. | Maalouf, G. | +15

CommentIn: Ophthalmology. 2022 Jul;129(7):e77. - PMID 35346510

30

PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma : a multicentre, single-arm, phase 2 study

enthalten in: The Lancet. Oncology | 2022

von Delyon, J. | Biard, L. | Renaud, M. | +12